GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36563
Submission : 2021-12-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28188
Submission : 2014-04-07
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12715
Submission : 1997-10-20
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12961
Submission : 1998-04-21
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22790
Submission : 2009-05-20
Status : Inactive
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FINISHED DOSAGE FORMULATIONS
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
Drug : VIEKIRA PAK (COPACKAGED)
Dosage Form : TABLET; ORAL
Application Number : 206619
Country : US
Patented : Yes
Drug : FENOFIBRATE
Dosage Form : TABLET; ORAL
Application Number : 217732
Country : US
Patented : No

Drug : APREPITANT
Dosage Form : CAPSULE; ORAL
Application Number : 207777
Country : US
Patented : No

Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65017
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
07 Feb 2025
Reply
04 Dec 2024
Reply
28 Aug 2024
Reply
07 Oct 2023
Reply
18 Jan 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]